North Ridge Wealth Advisors’s AbbVie ABBV Stock Holding History

North Ridge Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$53.7K	Hold	247	–	–	0.03%	81
2025 Q4	$56.4K	Hold	247	–	–	0.03%	78
2025 Q3	$57.2K	Hold	247	–	–	0.03%	81
2025 Q2	$45.8K	Hold	247	–	–	0.03%	80
2025 Q1	$51.8K	Hold	247	–	–	0.03%	72
2024 Q4	$43.9K	Buy	+247	New	+$45.4K	0.03%	77

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

North Ridge Wealth Advisors's ABBV Position: Q1 2026 in Review

North Ridge Wealth Advisors held its AbbVie (ABBV) position steady in Q1 2026 at 247 shares worth $53.7K. The position accounts for 0.03% of the portfolio, ranked #81.

North Ridge Wealth Advisors first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. The position peaked at $57.2K in Q3 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

North Ridge Wealth Advisors held 247 shares of AbbVie worth $53.7K as of Q1 2026.
North Ridge Wealth Advisors left its AbbVie share count unchanged in Q1 2026.
AbbVie made up 0.03% of North Ridge Wealth Advisors's portfolio in Q1 2026, its #81 holding.
North Ridge Wealth Advisors first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
North Ridge Wealth Advisors's AbbVie position peaked at $57.2K in Q3 2025.
4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on North Ridge Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.